What happened
FBI psychiatrist Gregory Saathoff says he’s treated only two women with postpartum psychosis, both decades earlier The Lindsay Clancy trial was heading for closing arguments on Wednesday, as a final witness for the prosecution laid out that he believed the Massachusetts mother knew right from wrong when she took the lives of her three young children before attempting to commit suicide in 2023.
Why it matters
AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.
Global context
The story is being tracked through Global Markets.
Who is affected
Global Markets
What to watch next
Readers should watch official responses, local reaction, source updates, and whether the story changes the next decision cycle.
The consequence layer
AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.
What To Watch Next
Three facts to keep in view
The Guardian
Designed for a concise world-news brief.
Used for editorial story mapping and source context.
Related Stories
‘Work is good for you’: how UK scheme could help tackle youth mental health crisis
Paid employment can boost confidence and wellbeing, says Pat McFadden as jobs guarantee scheme gets under way Work must be “part of the answer” to the mental health crisis among young people, the work and pensions secretary, Pat McFadden, has said as he met some of the first beneficiaries of Labour’s youth jobs guarantee scheme. He was speaking on a visit to Boots’s headquarters in Nottingham on Wednesday, where several 18- to 21-year-olds were taken on under the job guarantee – with their wages paid by the taxpayer for six months...
US drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.
Drugstores say Medicare's $50 obesity drug program is catching on
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
AtlasHour updates articles as new verified information becomes available. Corrections and source context can be sent to the newsroom.